Optimal age to discontinue long-term surveillance of intraductal papillary mucinous neoplasms: comparative cost-effectiveness of surveillance by age.

MLA

Tsuyoshi Hamada, et al. “Optimal Age to Discontinue Long-Term Surveillance of Intraductal Papillary Mucinous Neoplasms: Comparative Cost-Effectiveness of Surveillance by Age.” Gut, vol. 73, no. 6, June 2024, pp. 955–65. EBSCOhost, https://doi.org/10.1136/gutjnl-2023-330329.

APA

Tsuyoshi Hamada, Hiroki Oyama, Igarashi, A., Yoshikuni Kawaguchi, Mihye Lee, Hiroki Matsui, Nobuaki Michihata, Yousuke Nakai, Kiyohide Fushimi, Hideo Yasunaga, & Mitsuhiro Fujishiro. (2024). Optimal age to discontinue long-term surveillance of intraductal papillary mucinous neoplasms: comparative cost-effectiveness of surveillance by age. Gut, 73(6), 955–965. https://doi.org/10.1136/gutjnl-2023-330329

Chicago

Tsuyoshi Hamada, Hiroki Oyama, Ataru Igarashi, Yoshikuni Kawaguchi, Mihye Lee, Hiroki Matsui, Nobuaki Michihata, et al. 2024. “Optimal Age to Discontinue Long-Term Surveillance of Intraductal Papillary Mucinous Neoplasms: Comparative Cost-Effectiveness of Surveillance by Age.” Gut 73 (6): 955–65. doi:10.1136/gutjnl-2023-330329.